The use of the Ki-67 in deciding which patients with HR+ breast cancer can safely avoid chemotherapy
LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT
Dr. Goncalves Discusses the Development of a Standardized Ki-67 Assay
Who gets Breast Cancer Recurrences? - with Dr Tasha
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes...
Dr. Nielsen on the Challenges of Using Ki67 as a Tool in Breast Cancer
What Does My Tumor Grade Mean for Breast Cancer? Expert Insights
What are the grades and stages of breast cancer?
Role of Ki 67 Index in Grading of MTC
What is Ki67 and how is it used in treatment decision making?
Difference Between the Ki-67 Tumor Marker Test and the Oncotype DX Test
Oncotype DX for Breast Cancer
High Oncotype DX Score, What Does It Mean
Role of the Oncotype DX Breast Recurrence Score Test
Virtual Pink House: Reducing Recurrence Risk of HER2 Positive Breast Cancer
Does 21-gene recurrence score assay testingchange decisions? Dr. Adher Alsayed ( Day 1)
The Complexities of Battling Triple-negative Breast Cancer
What Is Triple Negative Breast Cancer ? with Dr Liz O'Riordan
Ki67 as a marker for making management decisions in breast cancer
The Breast Cancer Index® Test: Easy to Interpret Predictive and Prognostic Results
